Literature DB >> 4816133

Cerebral metabolic changes during treatment of subacute cerebral infarction by alpha and beta adrenergic blockade with phenoxybenzamine and propranolol.

J S Meyer, S Okamoto, K Shimazu, A Koto, T Ouchi, A Sari, A D Ericsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4816133     DOI： 10.1161/01.str.5.2.180

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  8 in total

1.  Beta-Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial.

Authors:  Hosseinali Khalili; Rebecka Ahl; Shahram Paydar; Gabriel Sjolin; Yang Cao; Hossein Abdolrahimzadeh Fard; Amin Niakan; Kamil Hanna; Bellal Joseph; Shahin Mohseni
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

2.  Drug action on adenylate kinase activity in cerebrospinal fluid of arteriosclerotic patients.

Authors:  G Frithz; G Ronquist; B Andersson
Journal:  Experientia       Date:  1980-12-15

Review 3.  β-Blockade use for Traumatic Injuries and Immunomodulation: A Review of Proposed Mechanisms and Clinical Evidence.

Authors:  Tyler J Loftus; Philip A Efron; Lyle L Moldawer; Alicia M Mohr
Journal:  Shock       Date:  2016-10       Impact factor: 3.454

4.  Beta-blockade benefits patients following a subarachnoid haemorrhage.

Authors:  G Neil-Dwyer; P Walter; J M Cruickshank
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 5.  Clinical use of beta-adrenoceptor blockade in systemic hypertension.

Authors:  J Nadelmann; W H Frishman
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

6.  Beneficial effects of adrenergic blockade in patients with subarachnoid haemorrhage.

Authors:  P Walter; G Neil-Dwyer; J M Cruickshank
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-05

7.  Beta-blockade in acute aneurysmal subarachnoid haemorrhage.

Authors:  G Hamann; A Haass; K Schimrigk
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

8.  Low dose beta blockade in acute stroke ("BEST" trial): an evaluation.

Authors:  D H Barer; J M Cruickshank; S B Ebrahim; J R Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.